The London deep tech startup OdorPi (now named Anemo Labs) has raised £700,000 in a seed funding round. These funds are intended for the commercialization of technology that allows artificial intelligence to perceive odors.
The funding round was co-led by Zinc and SFC Capital, with additional support from Innovate UK. OdorPi was founded in 2025 by Koe Sodipo.
The company is developing an electronic nose that integrates sensor hardware with machine learning models. This system is capable of detecting and classifying volatile organic compounds (VOCs)—chemical molecules responsible for odor. By analyzing these compounds in urine, the company aims to identify signs of diseases before physical symptoms appear.
The startup has created its own sampling platform, which allows it to collect and label up to 5,000 odors daily for model training. In initial testing, conducted using the Sniffin’ Sticks olfactory test protocol, the company demonstrated a classification accuracy of 84.15% across 12 different odor categories.
The new funding is planned to be directed towards developing sensor chemistry and expanding the odor data collection infrastructure. Sodipo emphasized that olfaction represents a non-invasive and continuous method for disease screening, with potential future applications in diagnosing urinary tract infections and certain types of cancer.
OdorPi's scientific team, which includes researchers with PhDs in electronics and sensor chemistry, is currently collaborating with clinical consultants to validate the diagnostic platform. Although the £700,000 is a modest contribution in the current deep tech market, it indicates investor confidence in the digitalization and scaling of a diagnostic method previously limited to manual clinical observation.

